In this week’s edition of InnovationRx, we look at a high-tech chair that could revolutionize cancer radiation therapy, AI chatbots for seniors and more. https://t.co/MXLKxUQgkg ...

Heidi Tlansky was preparing for a replacement surgery, taking care of her children and her dying mother when and all of a sudden I got this out of the blue routine mammogram breast cancer diagnosis. She was diagnosed with two different cancers back in 2012, one in each breast. For her left, she qualified for a less common targeted treatment known as intraoperative rad or IT.The way it works is, in my opinion, ingenious and amazing. Dr. . Alice Police is a breast surgical oncologist.She started three differe ...

Core Insights - Accuray Incorporated presented over 40 clinical studies at the ESTRO 2025 meeting, highlighting the effectiveness of its CyberKnife® System in treating prostate cancer at various stages [1][2] - The studies emphasize the system's precision and ability to treat high-risk and recurrent prostate cancer, promoting a non-invasive treatment option [1][2] - Accuray's symposium at the meeting attracted 350 healthcare professionals, focusing on advancements in genitourinary radiotherapy [3] Clinical Data and Outcomes - A retrospective analysis involving 262 men over 70 or with severe comorbidities showed favorable outcomes with CyberKnife SBRT, reporting low rates of acute and late urogenital and gastrointestinal toxicities [4] - An early trial on stereotactic salvage radiotherapy (SSRT) for prostate bed recurrence after prostatectomy indicated mild toxicity and a shorter treatment duration compared to standard approaches [5] Company Commitment and Innovation - Accuray is dedicated to advancing radiation therapy solutions, aiming to improve patient care and outcomes through continuous innovation [6]